Why study the T1D remission phase in the pediatric population?
作者信息
Johannesen Jesper
机构信息
Copenhagen University Hospital, Herlev, Denmark; Steno Diabetes Center Copenhagen, Copenhagen, Denmark; University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark.
出版信息
J Pediatr (Rio J). 2025 Mar-Apr;101(2):117-118. doi: 10.1016/j.jped.2024.12.001. Epub 2024 Dec 20.
Abstract
摘要
相似文献
1
Why study the T1D remission phase in the pediatric population?为什么要研究儿科人群中的1型糖尿病缓解期？
J Pediatr (Rio J). 2025 Mar-Apr;101(2):117-118. doi: 10.1016/j.jped.2024.12.001. Epub 2024 Dec 20.
2
The Theory of Hyperlipidemic Memory of Type 1 Diabetes.1型糖尿病的高脂血症记忆理论
Front Endocrinol (Lausanne). 2022 Mar 31;13:819544. doi: 10.3389/fendo.2022.819544. eCollection 2022.
3
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.候选生物标志物用于预测和监测儿科 1 型糖尿病的部分缓解。
Front Immunol. 2022 Feb 23;13:825426. doi: 10.3389/fimmu.2022.825426. eCollection 2022.
4
Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study.部分缓解和小儿 1 型糖尿病的早期阶段表现出免疫调节变化。一项初步研究。
Transl Res. 2019 Aug;210:8-25. doi: 10.1016/j.trsl.2019.03.002. Epub 2019 Mar 15.
5
Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: A longitudinal study.1 型糖尿病患儿缓解期免疫细胞和细胞因子谱的纵向研究。
Pediatr Diabetes. 2018 Aug;19(5):963-971. doi: 10.1111/pedi.12671. Epub 2018 Mar 27.
6
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.NK 细胞亚群在儿童 1 型糖尿病部分缓解期和早期的变化。
Front Immunol. 2021 Jan 25;11:611522. doi: 10.3389/fimmu.2020.611522. eCollection 2020.
7
The partial clinical remission phase of type 1 diabetes: early-onset dyslipidemia, long-term complications, and disease-modifying therapies.1型糖尿病的部分临床缓解期：早发性血脂异常、长期并发症及疾病改善疗法。
Front Endocrinol (Lausanne). 2025 Apr 16;16:1462249. doi: 10.3389/fendo.2025.1462249. eCollection 2025.
8
Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes.1 型糖尿病患儿和青少年缓解期的骨转换标志物。
Pediatr Diabetes. 2020 Mar;21(2):366-376. doi: 10.1111/pedi.12963. Epub 2019 Dec 27.
9
Increased anxiety symptoms in pediatric type 1 diabetes during the acute phase of COVID-19 lockdown.COVID-19 封锁期间，儿科 1 型糖尿病患儿焦虑症状加重。
J Pediatr Endocrinol Metab. 2022 Mar 28;35(5):627-630. doi: 10.1515/jpem-2022-0002. Print 2022 May 25.
10
The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes.DR9/DR9 基因型对 1 型糖尿病部分缓解频率和质量的不利影响。
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e293-e302. doi: 10.1210/clinem/dgab589.
本文引用的文献
1
An analysis of the remission phase in type 1 diabetes within a multiethnic Brazilian sample.巴西多民族样本中1型糖尿病缓解期的分析。
J Pediatr (Rio J). 2025 Mar-Apr;101(2):167-171. doi: 10.1016/j.jped.2024.09.005. Epub 2024 Nov 4.
2
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.INNODIA 1 型糖尿病自然史研究：一项欧洲新诊断儿童、青少年和成人队列研究。
Diabetologia. 2024 Jun;67(6):995-1008. doi: 10.1007/s00125-024-06124-5. Epub 2024 Mar 22.
3
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial.普乐可复和利巴韦林治疗初发 1 型糖尿病：一项 2 期随机试验。
Nat Med. 2023 Nov;29(11):2902-2908. doi: 10.1038/s41591-023-02576-1. Epub 2023 Oct 4.
4
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.维拉帕米对新诊断的儿童 1 型糖尿病患者胰岛β细胞功能的影响：一项随机临床试验。
JAMA. 2023 Mar 28;329(12):990-999. doi: 10.1001/jama.2023.2064.
5
Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.儿童 1 型糖尿病部分缓解期胰岛素敏感性的差异：一项纵向队列研究。
Diabet Med. 2022 Feb;39(2):e14702. doi: 10.1111/dme.14702. Epub 2021 Oct 6.
6
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.1 型糖尿病患者残余 C 肽分泌对血糖和微血管并发症的临床影响。
Diabetes Care. 2021 Feb;44(2):390-398. doi: 10.2337/dc20-0567. Epub 2020 Dec 10.
7
Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes.特定细胞类型的免疫表型可预测新发 1 型糖尿病中胰岛素分泌的丧失。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.125556.
8
Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.1 型糖尿病中三种免疫效应细胞类型的 DNA 甲基化变异性增加。
Nat Commun. 2016 Nov 29;7:13555. doi: 10.1038/ncomms13555.
9
Environmental risk factors for type 1 diabetes.1型糖尿病的环境风险因素。
Lancet. 2016 Jun 4;387(10035):2340-2348. doi: 10.1016/S0140-6736(16)30507-4.
10
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.确定1型糖尿病儿童疾病改善疗法的发展路径：一份共识报告。
Diabetes Care. 2015 Oct;38(10):1975-85. doi: 10.2337/dc15-1429.
Zotero 插件